Literature DB >> 3309773

Clinical results with a ceramic keratoprosthesis placed through the eyelid.

A M Kozarsky1, S H Knight, G O Waring.   

Abstract

The authors placed a ceramic keratoprosthesis through the eyelids of 11 consecutive patients: six with alkali injury, four with cicatricial pemphigoid, and one with Stevens-Johnson syndrome. The surgery was technically successful in ten patients. One patient experienced an intraoperative, expulsive choroidal hemorrhage, and the keratoprosthesis was not implanted. Six patients were followed for 21 to 56 months; three, who had no postoperative potential for visual improvement were followed for 2 to 6 months; and one patient died 14 months after surgery. Six patients achieved 20/20 to 20/100 corrected visual acuity at some point after surgery. At last examination, only three eyes (27%) saw 20/200 or better. Complications included eyelid cellulitis, extrusions, aqueous leaks, retroprosthetic membranes, endophthalmitis, and progressive glaucoma. The authors think mechanical torque by movement of eyelid and globe destabilizes the keratoprosthesis, producing many of the complications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309773     DOI: 10.1016/s0161-6420(87)33358-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  The soft keratoprosthesis.

Authors:  D R Caldwell
Journal:  Trans Am Ophthalmol Soc       Date:  1997

2.  Corneal graft after drug-induced toxic epidermal necrolysis (Lyell's disease).

Authors:  M T Rodrígues-Ares; F González; M V De Rojas; C Capeans; M Sánchez-Salorio
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

3.  New Dacron tissue colonisable keratoprosthesis: clinical experience.

Authors:  S Pintucci; F Pintucci; M Cecconi; S Caiazza
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

4.  Glass-metal keratoprosthesis: light and electron microscopical evaluation of experimental surgery on rabbit eyes.

Authors:  P L Cuperus; W L Jongebloed; P van Andel; J G Worst
Journal:  Doc Ophthalmol       Date:  1989-01       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.